Results 331 to 339 of about 345,011 (339)
Some of the next articles are maybe not open access.

GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma.

New England Journal of Medicine, 2023
BACKGROUND Immunotherapy with chimeric antigen receptor (CAR)-expressing T cells that target the disialoganglioside GD2 expressed on tumor cells may be a therapeutic option for patients with high-risk neuroblastoma.
F. del Bufalo   +34 more
semanticscholar   +1 more source

Neuroblastoma

Definitions, 2018
Neuroblastoma is a type of cancer that most often affects children. Neuroblastoma occurs when immature nerve cells called neuroblasts become abnormal and multiply uncontrollably to form a tumor.
S. Jason   +3 more
semanticscholar   +1 more source

Advancing therapy for neuroblastoma

Nature Reviews Clinical Oncology, 2022
B. Qiu, K. Matthay
semanticscholar   +1 more source

Single-cell transcriptomic analyses provide insights into the developmental origins of neuroblastoma

Nature Genetics, 2021
Selina Jansky   +14 more
semanticscholar   +1 more source

Revisions of the international criteria for neuroblastoma diagnosis, staging and response to treatment.

Progress in clinical and biological research, 1993
G. Brodeur   +9 more
semanticscholar   +1 more source

Neuroblastoma is composed of two super-enhancer-associated differentiation states

Nature Genetics, 2017
Tim van Groningen   +30 more
semanticscholar   +1 more source

Updates in Diagnosis, Management, and Treatment of Neuroblastoma.

Radiographics, 2018
C. Swift   +3 more
semanticscholar   +1 more source

Update on neuroblastoma.

Journal of Pediatric Surgery, 2019
E. Newman   +17 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy